Editor's Pick Viewpoint

On Becoming a Gold Standard Scientist—The Importance of Pilot Clinical Trials

JAMA 10.1001/jama.2026.19315

September 24, 2026 at 11:05 AM EDT

Read the full article

This Viewpoint discusses the recent National Institutes of Health announcement that its Career Development (K) awards cannot be used to conduct clinical trials, feasibility studies, or ancillary studies, which may negatively affect awardees’ ability to lead pilot clinical trials.

Corresponding Author: James Feinstein, MD, MPH, University of Colorado School of Medicine, 1890 N Revere Ct, Third Level, Mail Stop F443, Aurora, CO 80045 (james.feinstein@cuanschutz.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.19315

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks